Associations of proinflammatory cytokines with the risk of recurrent stroke.

BACKGROUND AND PURPOSE: There are few reports on proinflammatory cytokines and risk of primary or recurrent stroke. We studied the association of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-alpha) with recurrent stroke in a nested case-control study derived from the Perindopril...

Full description

Bibliographic Details
Main Authors: Welsh, P, Lowe, G, Chalmers, J, Campbell, D, Rumley, A, Neal, B, MacMahon, S, Woodward, M
Format: Journal article
Language:English
Published: 2008
_version_ 1797090963101843456
author Welsh, P
Lowe, G
Chalmers, J
Campbell, D
Rumley, A
Neal, B
MacMahon, S
Woodward, M
author_facet Welsh, P
Lowe, G
Chalmers, J
Campbell, D
Rumley, A
Neal, B
MacMahon, S
Woodward, M
author_sort Welsh, P
collection OXFORD
description BACKGROUND AND PURPOSE: There are few reports on proinflammatory cytokines and risk of primary or recurrent stroke. We studied the association of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-alpha) with recurrent stroke in a nested case-control study derived from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). METHODS: We performed a nested case-control study of 591 strokes (472 ischemic, 83 hemorrhagic, 36 unknown subtype) occurring during a randomized, placebo-controlled multicenter trial of perindopril-based therapy in 6105 patients with a history of stroke or transient ischemic attack. Controls were matched for age, treatment group, sex, region, and most recent qualifying event at entry to the parent trial. RESULTS: IL-6 and TNF-alpha, but not IL-18, were associated with risk of recurrent ischemic stroke independently of conventional risk markers. Adjusted odds ratios comparing the highest to lowest third of their distributions were 1.33 (95% CI, 1.00 to 1.78) for IL-6 and 1.46 (1.02 to 2.10) for TNF-alpha. No inflammatory marker was associated with hemorrhagic stroke risk. In multivariable models, IL-6 and TNF-alpha fully explained observed associations of C-reactive protein and fibrinogen with risk of ischemic stroke, but TNF-alpha retained borderline significance after full adjustment. CONCLUSIONS: Inflammatory markers associated with the acute-phase response (IL-6, TNF-alpha, C-reactive protein, and fibrinogen, but not IL-18) are associated with risk of recurrent stroke. These markers are dependent on each other in multivariable models, and once all were included, only TNF-alpha retained a borderline association. Markers of generalized inflammation of the acute-phase response are associated with recurrent stroke, rather than IL-6, C-reactive protein, or fibrinogen in particular.
first_indexed 2024-03-07T03:26:13Z
format Journal article
id oxford-uuid:b91e7952-1034-48b6-a4c4-46c792806eaf
institution University of Oxford
language English
last_indexed 2024-03-07T03:26:13Z
publishDate 2008
record_format dspace
spelling oxford-uuid:b91e7952-1034-48b6-a4c4-46c792806eaf2022-03-27T05:00:49ZAssociations of proinflammatory cytokines with the risk of recurrent stroke.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b91e7952-1034-48b6-a4c4-46c792806eafEnglishSymplectic Elements at Oxford2008Welsh, PLowe, GChalmers, JCampbell, DRumley, ANeal, BMacMahon, SWoodward, M BACKGROUND AND PURPOSE: There are few reports on proinflammatory cytokines and risk of primary or recurrent stroke. We studied the association of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-alpha) with recurrent stroke in a nested case-control study derived from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). METHODS: We performed a nested case-control study of 591 strokes (472 ischemic, 83 hemorrhagic, 36 unknown subtype) occurring during a randomized, placebo-controlled multicenter trial of perindopril-based therapy in 6105 patients with a history of stroke or transient ischemic attack. Controls were matched for age, treatment group, sex, region, and most recent qualifying event at entry to the parent trial. RESULTS: IL-6 and TNF-alpha, but not IL-18, were associated with risk of recurrent ischemic stroke independently of conventional risk markers. Adjusted odds ratios comparing the highest to lowest third of their distributions were 1.33 (95% CI, 1.00 to 1.78) for IL-6 and 1.46 (1.02 to 2.10) for TNF-alpha. No inflammatory marker was associated with hemorrhagic stroke risk. In multivariable models, IL-6 and TNF-alpha fully explained observed associations of C-reactive protein and fibrinogen with risk of ischemic stroke, but TNF-alpha retained borderline significance after full adjustment. CONCLUSIONS: Inflammatory markers associated with the acute-phase response (IL-6, TNF-alpha, C-reactive protein, and fibrinogen, but not IL-18) are associated with risk of recurrent stroke. These markers are dependent on each other in multivariable models, and once all were included, only TNF-alpha retained a borderline association. Markers of generalized inflammation of the acute-phase response are associated with recurrent stroke, rather than IL-6, C-reactive protein, or fibrinogen in particular.
spellingShingle Welsh, P
Lowe, G
Chalmers, J
Campbell, D
Rumley, A
Neal, B
MacMahon, S
Woodward, M
Associations of proinflammatory cytokines with the risk of recurrent stroke.
title Associations of proinflammatory cytokines with the risk of recurrent stroke.
title_full Associations of proinflammatory cytokines with the risk of recurrent stroke.
title_fullStr Associations of proinflammatory cytokines with the risk of recurrent stroke.
title_full_unstemmed Associations of proinflammatory cytokines with the risk of recurrent stroke.
title_short Associations of proinflammatory cytokines with the risk of recurrent stroke.
title_sort associations of proinflammatory cytokines with the risk of recurrent stroke
work_keys_str_mv AT welshp associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT loweg associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT chalmersj associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT campbelld associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT rumleya associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT nealb associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT macmahons associationsofproinflammatorycytokineswiththeriskofrecurrentstroke
AT woodwardm associationsofproinflammatorycytokineswiththeriskofrecurrentstroke